Adamson, V., Mitt, P., Pisarev, H., Metsvaht, T., Telling, K., Naaber, P., Maimets, M. 2012. Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case-control study. BMC Infectious Diseases, 31, 281.
https://doi.org/10.1186/1471-2334-12-281
Alshaikh, B., Yusuf, K., Sauve, R. 2013. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: Systematic review and meta-analysis. Journal of Perinatology, 33, 558–564.
https://doi.org/10.1038/jp.2012.167
Cai, S., Thompson, D. K., Anderson, P. J., Yang, J. Y. 2019. Short- and long-term neurodevelopmental outcomes of very preterm infants with neonatal sepsis: A systematic review and meta-analysis. Children (Basel), 6(12), 131.
https://doi.org/10.3390/children6120131
Chan, P. L. S., McFadyen, L., Quaye, A., Leister-Tebbe, H., Hendrick, V. M., Hammond, J., Raber, S. 2021. The use of extrapolation based on modeling and simulation to support high-dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft-tissue infections. CPT: Pharmacometrics & Systems Pharmacology, 10(6), 551–563.
https://doi.org/10.1002/psp4.12608
D’Agate, S., Musuamba, F. T., Della Pasqua, O. 2020. Dose rationale for amoxicillin in neonatal sepsis when referral is not possible. Frontiers in Pharmacology, 11, 521933.
https://doi.org/10.3389/fphar.2020.521933
Fleischmann-Struzek, C., Goldfarb, D. M., Schlattmann, P., Schlapbach, L. J., Reinhart, K., Kissoon, N. 2018. The global burden of paediatric and neonatal sepsis: A systematic review. The Lancet Respiratory Medicine, 6(3), 223–230.
https://doi.org/10.1016/S2213-2600(18)30063-8
Folgori, L., Tersigni, C., Hsia, .Y, Kortsalioudaki, C., Heath, P., Sharland, M., Bielicki, J. 2018. The relationship between Gram-negative colonization and bloodstream infections in neonates: A systematic review and meta-analysis. Clinical Microbiology and Infection, 24(3), 251–257.
https://doi.org/10.1016/j.cmi.2017.08.008
Folgori, L., Lutsar, I., Standing, J. F., Walker, A. S., Roilides, E., Zaoutis, T. E., Jafri, H., Giaquinto, C., Turner, M. A., Sharland, M. 2019. Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view. BMJ Open, 9(12), e032592.
https://doi.org/10.1136/bmjopen-2019-032592
Folgori, L., Di Carlo, D., Comandatore, F., Piazza, A., Witney, A. A., Bresesti, I., Hsia, Y., Laing, K., Monahan, I., Bielicki, J., Alvaro, A., Zuccotti, G. V., Planche, T., Heath, P. T., Sharland, M. 2021. Antibiotic susceptibility, virulome, and clinical outcomes in European infants with bloodstream infections caused by enterobacterales. Antibiotics (Basel), 10(6), 706.
https://doi.org/10.3390/antibiotics10060706
Germovsek, E., Lutsar, I., Kipper, K., Karlsson, M. O., Planche, T., Chazallon, C., Meyer, L., Trafojer, U. M. T., Metsvaht, T., Fournier, I., Sharland, M., Heath, P., Standing, J. F. 2018. NeoMero Consortium. Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: Results from the NeoMero studies. Journal of Antimicrobial Chemotherapy, 73(7), 1908–1916.
https://doi.org/10.1093/jac/dky128
Hallik, M., Ilmoja, M-L., Tasa, T., Standing, J. F., Takkis, K., Veigure, R., Kipper, K., Jalas, T., Raidmäe, M., Uibo, K., Starkopf, J., Metsvaht, T. 2019. Population pharmacokinetics and dosing of milrinone after patent ductus arteriosus ligation in preterm infants. Pediatric Critical Care Medicine, 20(7), 621–629.
https://doi.org/10.1097/PCC.0000000000001879
Hallik, M., Ilmoja, M-L., Standing, J. F., Soeorg, H., Jalas, T., Raidmäe, M., Uibo, K., Köbas, K., Sõnajalg, M., Täkkis, K. Veigure, T., Kipper, K., Starkopf, J., Metsvaht, T. 2020. Population pharmacokinetics and pharmacodynamic of dobutamine in neonates on the first days of life. British Journal of Clinical Pharmacology, 86(2), 318–328.
https://doi.org/10.1111/bcp.14146
Hallik, M., Soeorg, H., Kahre, T., Murumets, Ü., Ilmoja, M-L., Kipper, K., Metsvaht, T. 2022. Pharmacogenetics may explain part of the interindividual variability of dobutamine pharmacodynamics in neonates. British Journal of Clinical Pharmacology, 88(9), 4155–4162.
https://doi.org/10.1111/bcp.15357
Hill, L. F., Clements, M. N., Turner, M. A., Donà, D., Lutsar, I., Jacqz-Aigrain, E., Heath, P. T., Roilides, E., Rawcliffe, L., Alonso-Diaz, C., Baraldi, E., Dotta, A., Ilmoja, M-L., Mahaveer, A., Metsvaht, T., Mitsiakos, G., Papaevangelou, V., Sarafidis, K., Walker, A. S., Sharland, M., NeoVanc Consortium. 2022. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): A multicentre, randomised, open-label, phase 2b, non-inferiority trial. The Lancet Child & Adolescent Health, 6(1), 49–59.
https://doi.org/10.1016/S2352-4642(21)00305-9
Horváth-Puhó, E., van Kassel, M. N., Gonçalves, B. P., de Gier, B., Procter, S. R., Paul, P., van der Ende, A., Søgaard, K. K., Hahné, S. J. M., Chandna, J., Schrag, S. J., van de Beek, D., Jit, M., Sørensen, H. T., Bijlsma, M. W., Lawn, J. E. 2021. Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: A national matched cohort study. The Lancet Child & Adolescent Health, 5(6), 398–407.
https://doi.org/10.1016/S2352-4642(21)00022-5
Huncikova, Z., Vatne, A., Stensvold, H. J., Lang, A. M., Støen, R., Brigtsen, A. K., Salvesen, B., Øymar, K. A. A., Rønnestad, A., Klingenberg, C., Norwegian Neonatal Network 2023. Late-onset sepsis in very preterm infants in Norway in 2009–2018: A population-based study. Archives of Disease in Childhood. Fetal and Neonatal Edition, veebiväljaanne.
https://doi.org/10.1136/archdischild-2022-324977
Ince, I., Knibbe, C. A. J., Danhof, M., de Wildt, S. N. 2013. Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations. Clinical Pharmacokinetics, 52(5), 333–345.
https://doi.org/10.1007/s40262-013-0041-1
Jacqz-Aigrain, E., Leroux, S., Thomson, A. H., Allegaert, K., Capparelli, E. V., Biran, V., Simon, N., Meibohm, B., Lo, Y. L., Marques, R., Peris, J. E., Lutsar, I., Saito, J., Nakamura, H., van den Anker, J. N., Sharland, M., Zhao, W. 2019. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants. Journal of Antimicrobial Chemotherapy, 74(8), 2128–2138.
https://doi.org/10.1093/jac/dkz158
Jain, A., Sahni, M., El-Khuffash, A. F., Khadawardi, E., Sehgal, A., McNamara, P. J. 2012. Use of targeted neonatal echocardiography to prevent postoperative cardio-respiratory instability after patent ductus arteriosus ligation. The Journal of Pediatrics, 160(4), 584–589.
https://doi.org/10.1016/j.jpeds.2011.09.027
Kalamees, R., Soeorg, H., Metsvaht, T., Lutsar, I. 2023. Prospective validation of model-informed precision dosing of vancomycin in neonates and infants. Abstract No 1572, 41st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Lisbon, Portugal 8–12 May 2023.
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., Kauffman, R. E. 2003. Developmental pharmacology – drug disposition, action, and therapy in infants and children. The New England Journal of Medicine, 349(12), 1157–1167.
https://doi.org/10.1056/NEJMra035092
Lass, J., Käär, R., Jõgi, K., Varendi, H., Metsvaht, T., Lutsar, I. 2011. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. European Journal of Clinical Pharmacology, 67, 1263–1271.
https://doi.org/10.1007/s00228-011-1072-x
Lass, J., Mitt, P., Telling, K., Linask, E., Laius, O., Sepp, E., Naaber, P., Lutsar, I. 2020. Ambulatoorne antibiootikumide kasutus Eestis. Eesti Arst, 99(10), 604–613.
https://ojs.utlib.ee/index.php/EA/article/view/16870
Lutsar, I., Chazallon, C., Carducci, F. I., Trafojer, U., Abdelkader, B., de Cabre, V. M., Esposito, S., Giaquinto, C., Heath, P. T., Ilmoja, M-L., Katragkou, A., Lascoux, C., Metsvaht, T., Mitsiakos, G., Netzer, E., Pugni, L., Roilides, E., Saidi, Y., Sarafidis, K., Sharland, M., Usonis, V., Aboulker, J. P., NeoMero Consortium 2014. Current management of late onset neonatal bacterial sepsis in five European countries. European Journal of Pediatrics, 173(8), 997–1004.
https://doi.org/10.1007/s00431-014-2279-5
Lutsar, I., Chazallon, C., Trafojer, U., de Cabre, V. M., Auriti, C., Bertaina, C., Calo Carducci, F. I., Canpolat, F. E., Esposito, S., Fournier, I., Hallik, M., Heath, P. T., Ilmoja, M-L., Iosifidis, E., Kuznetsova, J., Meyer, L., Metsvaht, T., Mitsiakos, G., Pana, Z. D., Mosca, F., Pugni, L., Roilides, E., Rossi, P., Sarafidis, K., Sanchez, L., Sharland, M., Usonis, V., Warris, A., Aboulker, J. P., Giaquinto, C., NeoMero Consortium. 2020. Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial. PLoS One, 15(3), e0229380.
https://doi.org/10.1371/journal.pone.0229380
Lutsar, I., Metsvaht, T. 2010. Understanding pharmacokinetics/pharmaco-dynamics in managing neonatal sepsis. Current Opinion in Infectious Diseases, 23(3), 201–207.
https://doi.org/10.1097/QCO.0b013e328337bb42
Melin, P. 2011. Neonatal group B streptococcal disease: From pathogenesis to preventive strategies. Clinical Microbiology and Infection, 17(9), 1294–1303.
https://doi.org/10.1111/j.1469-0691.2011.03576.x
Metsvaht, T., Oselin, K., Ilmoja, M-L., Anier, K., Lutsar, I. 2007. Pharmaco-kinetics of penicillin g in very-low-birth-weight neonates. Antimicrobial Agents and Chemotherapy, 51(6), 1995–2000.
https://doi.org/10.1128/AAC.01506-06
Metsvaht, T., Ilmoja, M-L., Parm, Ü., Maipuu, L., Merila, M., Lutsar, I. 2010. Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis. Acta Paediatrica, 99(5), 665–672.
https://doi.org/10.1111/j.1651-2227.2010.01687.x
Metsvaht, T., Ilmoja, M-L., Parm, Ü., Merila, M., Maipuu, L., Müürsepp, P., Julge, K., Sepp, E., Lutsar, I. 2011. Ampicillin versus penicillin in the empiric therapy of extremely low-birthweight neonates at risk of early onset sepsis. Pediatrics International, 53(6), 873–880.
https://doi.org/10.1111/j.1442-200x.2011.03468.x
Metsvaht, T., Nellis, G., Varendi, H., Nunn, A. J., Graham, S., Rieutord, A., Storme, T., McElnay, J., Mulla, H., Turner, M. A., Lutsar, I. 2015. High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: Implications for research and dissemination. BMC Pediatrics, 15, 41.
https://doi.org/10.1186/s12887-015-0359-y
Metsvaht, T., Soeorg, H., O’Sullivan, C., Heath, P. T., Lutsar, I. on behalf of NeoMero Consortium 2019. Long-term outcome of late onset neonatal sepsis (LOS) in NeoMero studies. – World Society of Pediatric Infectious Disease Congress; Manila, the Philippines, 5–8 November 2019.
Metsvaht, T., Soeorg, H., O’Sullivan, C., Heath, P. T., Challazon, C. C., Giaquinto, C., Lutsar, I. on behalf of the NeoMero Consortium. 2020. Long-term outcome of neonates with late onset neonatal sepsis (LOS) with and without meningitis in NeoMero studies. – 38th Annual Meeting of European Society of Paediatric Infectious Disease Congress ESPID 2020 (online), October 26–30, 2020.
https://espidmeeting.org
Mitt, P., Metsvaht, T., Adamson, V., Telling, K., Naaber, P., Lutsar, I., Maimets, M. 2014. Five-year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit. Journal of Hospital Infection, 86(2), 95–99.
https://doi.org/10.1016/j.jhin.2013.11.002
Oeser, C., Lutsar, I., Metsvaht, T., Turner, M. A., Heath, P. T., Sharland, M. 2013. Clinical trials in neonatal sepsis. Journal of Antimicrobial Chemotherapy, 68(12), 2733–2745.
https://doi.org/10.1093/jac/dkt297
Padari, H., Metsvaht, T., Kõrgvee, L. T., Germovsek, E., Ilmoja, M. L., Kipper, K., Herodes, K., Standing, J. F., Oselin, K., Lutsar, I. 2012. Short versus long infusion of meropenem in very-low-birth-weight neonates. Antimicrobial Agents and Chemotherapy, 56(9), 4760–4764.
https://doi.org/10.1128/aac.00655-12
Padari, H., Metsvaht, T., Germovsek, E., Barker, C. I., Kipper, K., Herodes, K., Standing, J. F., Oselin, K., Tasa, T., Soeorg, H., Lutsar, I. 2018. Pharmaco-kinetics of penicillin G in preterm and term neonates. Antimicrobial Agents and Chemotherapy, 62(5), e02238-17.
https://doi.org/10.1128/AAC.02238-17
Padari, H., Soeorg, H., Tasa, T., Metsvaht, T., Kipper, K., Herodes, K., Oselin, K., Hallik, M., Ilmoja, M-L., Lutsar, I. 2021. Ampicillin pharmacokinetics during first week of life in preterm and term neonates. The Pediatric Infectious Disease Journal, 40(5), 464–472.
https://doi.org/10.1097/inf.0000000000003061
Paradisis, M., Jiang, X., McLachlan, A. J., Evans, N., Kluckow, M., Osborn, D. 2007. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition, 92(3), F204–F209.
https://doi.org/10.1136/adc.2005.092817
Parm, Ü., Metsvaht, T., Sepp, E., Ilmoja, M-L., Pisarev, H., Pauskar, M., Lutsar, I. 2011. Mucosal surveillance cultures in predicting Gram-negative late-onset sepsis in neonatal intensive care units. Journal of Hospital Infection, 78(4), 327–332.
https://doi.org/10.1016/j.jhin.2011.03.025
Parm, Ü., Metsvaht, T., Sepp, E., Ilmoja, M-L., Pisarev, H., Pauskar, M., Lutsar, I. 2020. Impact of empiric antibiotic regimen on bowel colonization in neonates with suspected early onset sepsis. European Journal of Clinical Microbiology & Infectious Diseases, 29, 807–816.
https://doi.org/10.1007/s10096-010-0931-1
Parm, Ü., Tiit-Vesingi, A., Soeorg, H., Štšepetova, J., Truusalu, K., Vorobjov, S., Lutsar, I., Metsvaht, T. 2023. Effect of early directed implementation of family-integrated care measures on colonisation with Enterobacteriaceae in preterm neonates in NICU. BMJ Paediatrics Open, ilmumas (bmjpo-2022-001712.R2).
https://doi.org/10.1136/bmjpo-2022-001712
Rhodin, M. M., Anderson, B. J., Peters, A. M., Coulthard, M. G., Wilkins, B., Cole, M., Chatelut, E., Grubb, A., Veal, G. J., Keir, M. J., Holford, N. H. G. 2009. Human renal function maturation: A quantitative description using weight and postmenstrual age. Pediatric Nephrology, 24, 67–76.
https://doi.org/10.1007/s00467-008-0997-5
Sepp, E., Lutsar, I., Toompere, K., Mitt, P., Telling, K., Lass, J., Naaber, P. 2020. Haiglaväliste infektsioonitekitajate antibiootikumiresistentsus. Eesti Arst, 99(10), 614–621,
https://ojs.utlib.ee/index.php/EA/article/view/16871
Soeorg, H., Huik, K., Parm, Ü, Ilmoja, M-L., Metelskaja, N., Metsvaht, T., Lutsar, I. 2013. Genetic relatedness of coagulase-negative Staphylococci from gastro-intestinal tract and blood of preterm neonates with late-onset sepsis. The Pediatric Infectious Disease Journal, 32(4), 389–393.
https://doi.org/10.1097/inf.0b013e3182791abd
Soeorg, H., Huik, K., Parm, Ü., Ilmoja, M-L., Metsvaht, T., Lutsar, I. 2017. Molecular epidemiology of Staphylococcus epidermidis in neonatal intensive care units. APMIS (Journal of Pathology, Microbiology and Immunology), 125(1), 63–73.
https://doi.org/10.1111/apm.12637
Soeorg, H., Treumuth, S., Metsvaht, H. K., Eelmäe, I., Merila, M., Ilmoja, M-L., Lutsar, I., Metsvaht, T. 2018. Higher intake of coagulase-negative staphylococci from maternal milk promotes gut colonization with mecA-negative Staphylococcus epidermidis in preterm neonates. Journal of Perinatololgy, 38, 1344–1352.
https://doi.org/10.1038/s41372-018-0183-y
Soeorg, H., Padari, H., Kipper, K., Ilmoja, M-L., Lutsar, I., Metsvaht, T. 2022. Pharmacokinetics of gentamicin components C1, C1a, and C2/C2a/C2b and subsequent decline in glomerular filtration rate in neonates. The AAPS Journal, 24, 77.
https://doi.org/10.1208/s12248-022-00727-9
Tang, B. H., Guan, Z., Allegaert, K., Wu, Y. E., Manolis, E., Leroux, S., Yao, B. F., Shi, H. Y., Li, X., Huang, X., Wang, W. Q., Shen, A. D., Wang, X. L., Wang, T. Y., Kou, C., Xu, H. Y., Zhou, Y., Zheng, Y., Hao, G. X., Xu, B. P., Thomson, A. H., Capparelli, E. V., Biran, V., Simon, N., Meibohm, B., Lo, Y. L., Marques, R., Peris, J. E., Lutsar, I., Saito, J., Burggraaf, J., Jacqz-Aigrain, E., van den Anker, J., Zhao, W. 2021. Drug clearance in neonates: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction. Clinical Pharmacokinetics, 60, 1435–1448.
https://doi.org/10.1007/s40262-021-01033-x
Tasa, T., Metsvaht, T., Kalamees, R., Vilo, J., Lutsar, I. 2017. DosOpt: A tool for personalized Bayesian dose adjustment of vancomycin in neonates. Therapeutic Drug Monitoring, 39(6), 604–613.
https://doi.org/10.1097/FTD.0000000000000456
The Lancet (Editorial) 2022. Antimicrobial resistance: Time to -repurpose the Global Fund. The Lancet, 399(10322), 335.
https://doi.org/10.1016/S0140-6736(22)00091-5
Ting, J. Y., Resende, M., More, K., Nicholls, D., Weisz, D. E., El-Khuffash, A., Jain, A., McNamara, P. J. 2016. Predictors of respiratory instability in neonates undergoing patient ductus arteriosus ligation after the introduction of targeted milrinone treatment. The Journal of Thoracic and Cardiovascular Surgery, 152(2), 498–504.
https://doi.org/10.1016/j.jtcvs.2016.03.085
Versporten, A., Bielicki, J., Drapier, N., Sharland, M., Goossens, H., ARPEC Project Group 2016. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children. Journal of Antimicrobial Chemotherapy, 71(4), 1106–1117.
https://doi.org/10.1093/jac/dkv418
